SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?

Bibliographic Details
Main Author: S. Tolaney
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623000826
_version_ 1797869898143105024
author S. Tolaney
author_facet S. Tolaney
author_sort S. Tolaney
collection DOAJ
first_indexed 2024-04-10T00:19:49Z
format Article
id doaj.art-4b024b749db64f8fafd5cb624ca87dfc
institution Directory Open Access Journal
issn 1532-3080
language English
last_indexed 2024-04-10T00:19:49Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Breast
spelling doaj.art-4b024b749db64f8fafd5cb624ca87dfc2023-03-16T05:01:40ZengElsevierBreast1532-30802023-03-0168S3SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?S. Tolaneyhttp://www.sciencedirect.com/science/article/pii/S0960977623000826
spellingShingle S. Tolaney
SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
Breast
title SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
title_full SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
title_fullStr SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
title_full_unstemmed SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
title_short SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
title_sort sl 1 the future of innovation why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs
url http://www.sciencedirect.com/science/article/pii/S0960977623000826
work_keys_str_mv AT stolaney sl1thefutureofinnovationwhyareweconductingclinicaltrialsincountriesthatareunlikelytobeabletoaffordinnovativedrugs